Rita Keynan
Corporate Officer/Principal at PAINREFORM LTD.
Profile
Rita Keynan is currently the Vice President-Pharmaceutical Operations at PainReform Ltd.
Her former job was as the Executive Director-Drug Development at VYNE Pharmaceuticals Ltd.
She received her undergraduate and graduate degrees from The Hebrew University of Jerusalem.
Rita Keynan active positions
| Companies | Position | Start |
|---|---|---|
| PAINREFORM LTD. | Corporate Officer/Principal | 2021-01-05 |
Former positions of Rita Keynan
| Companies | Position | End |
|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | - |
Training of Rita Keynan
| The Hebrew University of Jerusalem | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PAINREFORM LTD. | Health Technology |
| Private companies | 1 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Stock Market
- Insiders
- Rita Keynan
